The evidence base for the treatment of lupus nephritis in the new millennium.
Adu
D
D
D000477:Alkylating Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000379:methods* / Q000639:trends*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000628:therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009398:Nephrology / Q000639:trends*; D010951:Plasma Exchange; D016032:Randomized Controlled Trials as Topic; D013256:Steroids / Q000627:therapeutic use
D000477:Alkylating Agents; D007166:Immunosuppressive Agents; D013256:Steroids; D009173:Mycophenolic Acid; D001379:Azathioprine